All articles tagged with #hypoglycemia
MIT has developed a small, implantable device that stores and automatically releases glucagon to prevent dangerous blood sugar drops in diabetics, potentially improving emergency treatment and reducing hypoglycemia risks, especially during sleep or for children.
MIT engineers have developed a small implantable device that automatically releases glucagon to treat dangerously low blood sugar levels in people with type 1 diabetes, potentially improving emergency response and safety.
Intermittent fasting may benefit motivated patients with type 2 diabetes who can monitor blood sugar and adjust medications, but it poses risks like hypoglycemia and nutritional deficiencies. Medical professionals should carefully evaluate individual patient circumstances, emphasize nutritious meals, and monitor hydration and medication adjustments to ensure safety.
Low blood sugar, or hypoglycemia, occurs when blood glucose drops below 70 mg/dL and can cause symptoms like dizziness, shakiness, irritability, rapid heartbeat, nausea, and hunger. It is most common in people with diabetes but can also affect others due to various health factors. To manage blood sugar levels, experts recommend eating balanced meals with fiber, protein, and healthy fats, eating regularly, and monitoring symptoms closely. Severe hypoglycemia is a medical emergency that requires immediate attention.
Anxiety and low blood sugar (hypoglycemia) can present similar symptoms, making it challenging to distinguish between the two. Symptoms like headaches, restlessness, and rapid heartbeat can occur in both conditions due to the body's fight-or-flight response. To differentiate, experts suggest using glucose monitors or considering recent dietary habits and stressors. Treating low blood sugar is prioritized, especially in diabetics, using fast-acting carbohydrates. For anxiety, relaxation techniques and professional guidance are recommended. Consulting a healthcare team can provide a comprehensive treatment plan.
Three cases of hypoglycemia in the US were linked to suspected fake versions of Novo Nordisk's diabetes drug Ozempic, with one case involving a compounded version. Explosive demand for Ozempic and similar drugs for weight loss has fueled a global market for counterfeit versions. Austrian and Lebanese health authorities also reported cases of hypoglycemia linked to suspected fake Ozempic. The FDA is investigating these cases, and Novo Nordisk reported finding some samples of compounded semaglutide to be impure.
Three Americans were hospitalized with life-threateningly low blood pressure after injecting themselves with suspected fake versions of the diabetes drug Ozempic, leading to concerns about the nationwide shortage of the drug and the availability of counterfeit versions online. The Food and Drug Administration (FDA) is investigating the cases, and warnings have been issued about the dangers of purchasing Ozempic from unlicensed sources. Reports of fake Ozempic pens have also emerged from other countries, with some cases resulting in hospitalization due to hypoglycemia.
Eleven people in Lebanon experienced dangerously low blood sugar levels, with one requiring hospitalization, after injecting suspected fake versions of Novo Nordisk's diabetes drug Ozempic. The Lebanese Ministry of Public Health suspects the drugs are counterfeit due to differences in dosage compared to authentic Ozempic injector pens. Counterfeit Ozempic has been found in at least 17 countries, prompting warnings to pharmacies and consumers. Investigations are ongoing to identify the source and batch numbers of the fake drugs. Novo Nordisk has created a guide to help healthcare providers spot fake drugs. Lebanon has a high obesity rate, which is closely linked to type 2 diabetes.
On World Diabetes Day, it is important to raise awareness about low blood sugar or hypoglycemia, which can affect people with diabetes. Common causes include prolonged fasting overnight, certain medications, increased physical activity, organ failure, hormonal imbalances, gastrointestinal issues, and low-carbohydrate diets. Symptoms of low blood sugar in the morning include fast heartbeat, shaking, sweating, nervousness or anxiety, irritability or confusion, dizziness, loss of coordination, and headache. Treatment options range from following the 15-15 rule to using injectable glucagon in severe cases.
A rescued baby walrus, who was receiving "round-the-clock" cuddles as part of his treatment, has died at the Alaska SeaLife Center. The Pacific walrus calf, believed to be around a month old, was found alone and struggling with health issues. Despite efforts to save him, his condition worsened, and he passed away. A necropsy will be performed to determine the cause of death. Walruses face challenges due to declining sea ice caused by global warming, making it difficult for them to find food and rest.
The FDA has approved Lantidra, the first cellular therapy for the treatment of type 1 diabetes. Lantidra is made from deceased donor pancreatic cells and is intended for adults with type 1 diabetes who experience severe hypoglycemia despite intensive diabetes management. The therapy works by infusing allogeneic islet beta cells, which can produce enough insulin to potentially eliminate the need for daily insulin injections. However, adverse reactions such as nausea, fatigue, and abdominal pain were observed, and some patients had to discontinue immunosuppressive medications, resulting in the loss of islet cell function.
Taking sulfonylureas sold as "street Valium" can lead to severe hypoglycemia that may result in emergency department (ED) visits. Sulfonylureas have no potential for abuse, but they physically resemble Valiums and are easier for illicit drug dealers to obtain because they're not a controlled substance, and they can be sold for considerably more money. A typical urine toxicology screen for drugs wouldn't detect a sulfonylurea. Ocreotide, a long-acting somatostatin agonist, is a unique antidote for sulfonylurea-induced hypoglycemia.